
Markets Rally, But Procter & Gamble Health Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-04-02 09:39:17Despite a broader market rebound, Procter & Gamble Health Ltd has slipped to a fresh 52-week low of Rs 4,725.05 on 2 Apr 2026, marking a notable divergence from sector and benchmark trends.
Read full news article
Procter & Gamble Health Ltd is Rated Sell
2026-03-26 10:10:02Procter & Gamble Health Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Procter & Gamble Health Ltd Stock Falls to 52-Week Low of Rs 4740
2026-03-16 10:32:24Procter & Gamble Health Ltd has reached a new 52-week low of Rs.4740, marking a significant decline amid broader market weakness and persistent underperformance relative to its sector and benchmark indices.
Read full news article
Procter & Gamble Health Ltd is Rated Sell
2026-03-15 10:10:02Procter & Gamble Health Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Procter & Gamble Health Ltd Stock Falls to 52-Week Low of Rs.4781
2026-03-09 12:02:34Procter & Gamble Health Ltd has reached a new 52-week low today, with its stock price touching Rs.4781. This marks a significant decline amid broader market weakness and ongoing challenges within the Pharmaceuticals & Biotechnology sector.
Read full news article
Procter & Gamble Health Ltd Falls to 52-Week Low of Rs.4824.05
2026-03-05 12:22:54Procter & Gamble Health Ltd has reached a new 52-week low of Rs.4824.05, marking a significant decline in its stock price amid broader market movements and sectoral pressures. The stock has underperformed its sector and key indices, reflecting a combination of subdued financial results and valuation concerns.
Read full news article
Procter & Gamble Health Ltd is Rated Sell
2026-03-04 10:10:02Procter & Gamble Health Ltd is rated Sell by MarketsMOJO. This rating was last updated on 07 Jan 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 04 March 2026, providing investors with the latest perspective on the company’s position.
Read full news article
Procter & Gamble Health Ltd Stock Falls to 52-Week Low of Rs.4845.15
2026-03-02 11:19:49Procter & Gamble Health Ltd’s share price declined to a fresh 52-week low of Rs.4845.15 today, marking a significant milestone in the stock’s recent performance. Despite a slight rebound after two consecutive days of falls, the stock remains below all key moving averages, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.
Read full news article
Procter & Gamble Health Ltd Stock Hits 52-Week Low Amidst Market Downturn
2026-02-27 15:15:44Procter & Gamble Health Ltd’s stock reached a fresh 52-week low of Rs.4872 today, marking a significant decline amid broader market weakness and company-specific performance factors. The stock has underperformed its sector and key benchmarks, reflecting a challenging period for the pharmaceuticals and biotechnology company.
Read full news articleBoard Meeting Intimation for Intimation Of Board Meeting
27-Mar-2026 | Source : BSEProcter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on May 26 2026
Closure of Trading Window
27-Mar-2026 | Source : BSEIntimation for closure of trading window
Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited
06-Feb-2026 | Source : BSEDear Sir Please find attached communication in respect of deduction of TDS on the amount of dividend income from declaration of interim dividend for the Financial year 2025-26.
Corporate Actions
26 May 2026
Procter & Gamble Health Ltd has declared 1100% dividend, ex-date: 12 Feb 26
No Splits history available
No Bonus history available
No Rights history available






